Document is current
Any future updates will be listed below
-
Authors
Patel, Rima
Fukui, Jami
Klein, Paula
Moshier, Erin
Kocyigit, Hulya
Fiedler, Laura
Bucwinska, Weronika
Xing, Xiao Y.
Shapiro, Charles
Goel, Anupama
Fasano, Julie
Shao, Theresa
Bhardwaj, Aarti
Kim, Esther
Vaccaro, Rita
Lee, Karen
Wilck, Eric
Tiersten, Amy
-
Funding
Funding for this research was provided by:
National Institutes of Health (5P30CA196521)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 1 August 2025
First Online: 16 August 2025
Declarations
:
: A.T. reports a consulting/advisory role for Puma Biotechnology, Immunomedics, AstraZeneca, Novartis, eisai and Roche/Genentech. All other authors report no relevant conflicts of interest.
: The protocol was approved by the Icahn School of Medicine at Mount Sinai’s Institutional Review Boards and conducted in accordance with the Declaration of Helsinki.
: All patients provided written informed consent.
